Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.105 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2026 Add to My Watchlist

Price and Volume

Volume	18
Open	2.105
Bid (Size)	2.060 (400)
Ask (Size)	2.790 (100)
Prev. Close	2.105
Today's Range	2.105 - 2.105
52wk Range	1.650 - 3.065
Shares Outstanding	5,567,490
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

June 01, 2026

Via ACCESS Newswire

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

May 18, 2026

Via ACCESS Newswire

Performance

YTD	-24.0%	-24.0%
1 Month	+0.2%	+0.2%
3 Month	-19.0%	-19.0%
6 Month	-18.1%	-18.1%
1 Year	+6.9%	+6.9%

More News

Aytu (AYTU) Q3 2026 Earnings Transcript ↗

May 13, 2026

Via The Motley Fool

Aytu BioPharma (NASDAQ:AYTU) Surges 23% as EXXUA Launch Gains Early Traction in Mixed Q3 Results ↗

May 13, 2026

Via Chartmill

Aytu BioPharma Inc (NASDAQ:AYTU) Posts Q2 Revenue Beat Amid EXXUA Launch Costs ↗

February 03, 2026

Via Chartmill

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

May 13, 2026

Via ACCESS Newswire

Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026

May 06, 2026

Via ACCESS Newswire

Aytu BioPharma AYTU Q2 2026 Earnings Transcript ↗

February 03, 2026

Via The Motley Fool

Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results

February 03, 2026

Via ACCESS Newswire

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

January 20, 2026

Via ACCESS Newswire

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

January 20, 2026

Via ACCESS Newswire

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

January 13, 2026

Via ACCESS Newswire

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

January 12, 2026

Via ACCESS Newswire

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

December 18, 2025

Via ACCESS Newswire

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

December 15, 2025

Via ACCESS Newswire

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

November 24, 2025

Via ACCESS Newswire

Aytu BioPharma Inc (NASDAQ:AYTU) Reports Q1 2026 Revenue Beat and Progress on EXXUA Launch ↗

November 13, 2025

Via Chartmill

Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results

November 13, 2025

Via ACCESS Newswire

Insights into Aytu BioPharma's Upcoming Earnings ↗

November 12, 2025

Via Benzinga

Aytu BioPharma to Report Fiscal 2026 First Quarter Operational and Financial Results on November 13, 2025

November 05, 2025

Via ACCESS Newswire

Aytu BioPharma Announces Patent Term Extension for EXXUA(TM)

October 28, 2025

Via ACCESS Newswire

Aytu BioPharma to Present at Upcoming October 2025 Conferences

October 10, 2025

Via ACCESS Newswire

11 Company Presentations Today at The MicroCap Rodeo Conference

September 25, 2025

Via ACCESS Newswire

Aytu BioPharma to Present at Upcoming September 2025 Conferences

September 24, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Aytu BioPharma, Inc. - Common Stock publicly traded?

Yes, Aytu BioPharma, Inc. - Common Stock is publicly traded.

What exchange does Aytu BioPharma, Inc. - Common Stock trade on?

Aytu BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aytu BioPharma, Inc. - Common Stock?

The ticker symbol for Aytu BioPharma, Inc. - Common Stock is AYTU on the Nasdaq Stock Market

What is the current price of Aytu BioPharma, Inc. - Common Stock?

The current price of Aytu BioPharma, Inc. - Common Stock is 2.105

When was Aytu BioPharma, Inc. - Common Stock last traded?

The last trade of Aytu BioPharma, Inc. - Common Stock was at 06/17/26 04:00 PM ET

What is the market capitalization of Aytu BioPharma, Inc. - Common Stock?

The market capitalization of Aytu BioPharma, Inc. - Common Stock is 11.72M

How many shares of Aytu BioPharma, Inc. - Common Stock are outstanding?

Aytu BioPharma, Inc. - Common Stock has 12M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.